EPISODE · Mar 12, 2026 · 3 MIN
Semaglutide vs Tirzepatide (Ozempic vs Zepbound): Key Differences for Weight Loss & Blood Sugar
from The Vagina Doctor Podcast w/ Duncan Turner M.D. · host The Vagina Doctor Podcast
The Vagina Doctor Podcast with Duncan Turner MDSophie, a nurse practitioner at Turner Medical Arts, explains two main GLP-1 medications—semaglutide and tirzepatide—and how they differ. She describes semaglutide (Ozempic) as a GLP-1–only medication that slows gastric emptying to help people feel full faster, can cause constipation and nausea, and improves metabolic function by lowering blood sugars gradually, making it helpful for people with diabetes and weight to lose. She then outlines why tirzepatide (Zepbound) is her preferred option: it combines GLP-1 and GIP, with GIP receptors on fat cells that help target abdominal and visceral fat, leading to better weight loss and improved blood-sugar management, and it is better tolerated with fewer side effects.00:00 Welcome to the Channel00:30 GLP-1s Overview00:58 Semaglutide Basics01:31 Side Effects and Tolerance01:44 Blood Sugar Benefits02:26 Why Tirzepatide Wins02:43 GIP and Fat Loss03:19 Final Takeaways
Embed this episode
NOW PLAYING
Semaglutide vs Tirzepatide (Ozempic vs Zepbound): Key Differences for Weight Loss & Blood Sugar
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.